Glatiramer

Category: Multiple Sclerosis

Glatiramer acetate (also known as Copolymer 1, Cop-1), sold under the brand name Copaxone among others, is an immunomodulator medication used to treat multiple sclerosis.[1][2] Glatiramer acetate is approved in the United States to reduce the frequency of relapses, but not for reducing the progression of disability. Observational studies, but not randomized controlled trials, suggest that it may reduce progression of disability. While a conclusive diagnosis of ... [wikipedia]

Dosage List

Glatiramer Acetate 20 mg/ml Subcutaneous Injection, Solution
NDC: 0378-6960
Labeler:
Mylan Pharmaceuticals Inc.
Glatiramer Acetate 40 mg/ml Subcutaneous Injection, Solution
NDC: 0378-6961
Labeler:
Mylan Pharmaceuticals Inc.
Glatiramer Acetate 20 mg/ml Subcutaneous Injection, Solution
NDC: 11797-764
Labeler:
Italfarmaco Spa
Glatiramer Acetate 40 mg/ml Subcutaneous Injection, Solution
NDC: 11797-765
Labeler:
Italfarmaco Spa
Glatiramer Acetate 20 mg/ml Subcutaneous Injection, Solution
NDC: 47335-990
Labeler:
Sun Pharmaceutical Industries, Inc.
Glatiramer Acetate 40 mg/ml Subcutaneous Injection, Solution
NDC: 47335-991
Labeler:
Sun Pharmaceutical Industries, Inc.
Glatiramer Acetate 20 mg/ml Subcutaneous Injection, Solution
NDC: 70710-1548
Labeler:
Zydus Pharmaceuticals USA Inc.
Glatiramer Acetate 40 mg/ml Subcutaneous Injection, Solution
NDC: 70710-1549
Labeler:
Zydus Pharmaceuticals USA Inc.

Related Brands

Drugs with the same active ingredients